Stocrin 600 mg Norge - norsk - Statens legemiddelverk

stocrin 600 mg

orifarm as - efavirenz - tablett, filmdrasjert - 600 mg

ReoPro 2 mg/ ml Norge - norsk - Statens legemiddelverk

reopro 2 mg/ ml

janssen biologics b.v - abciksimab - injeksjons-/infusjonsvæske, oppløsning - 2 mg/ ml

ReoPro 2 mg/ ml Norge - norsk - Statens legemiddelverk

reopro 2 mg/ ml

2care4 - abciksimab - injeksjons-/infusjonsvæske, oppløsning - 2 mg/ ml

Ultravist 240 mg I/ ml Norge - norsk - Statens legemiddelverk

ultravist 240 mg i/ ml

bayer ab - solna - jopromid - injeksjons-/infusjonsvæske, oppløsning - 240 mg i/ ml

Ultravist 150 mg I/ ml Norge - norsk - Statens legemiddelverk

ultravist 150 mg i/ ml

bayer ab - solna - jopromid - injeksjons-/infusjonsvæske, oppløsning - 150 mg i/ ml

Ultravist 300 mg I/ ml Norge - norsk - Statens legemiddelverk

ultravist 300 mg i/ ml

bayer ab - solna - jopromid - injeksjons-/infusjonsvæske, oppløsning - 300 mg i/ ml

Ultravist 370 mg I/ ml Norge - norsk - Statens legemiddelverk

ultravist 370 mg i/ ml

bayer ab - solna - jopromid - injeksjons-/infusjonsvæske, oppløsning - 370 mg i/ ml

Adcirca (previously Tadalafil Lilly) Den europeiske union - norsk - EMA (European Medicines Agency)

adcirca (previously tadalafil lilly)

eli lilly nederland b.v. - tadalafil - hypertensjon, pulmonal - urologika - adultstreatment of pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity (see section 5. effekt har blitt vist i idiopatisk pah (ipah) og i pah relatert til kollagenvaskulær sykdom. paediatric populationtreatment of paediatric patients aged 2 years and above with pulmonary arterial hypertension (pah) classified as who functional class ii and iii.

Adempas Den europeiske union - norsk - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hypertensjon, pulmonal - antihypertensive midler for pulmonal arteriell hypertensjon - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har vært vist i en pah befolkningen, herunder aetiologies av idiopatisk eller heritable pah eller pah assosiert med bindevev sykdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Digoxin DAK 62.5 mikrog Norge - norsk - Statens legemiddelverk

digoxin dak 62.5 mikrog

2care4 aps - digoksin - tablett - 62.5 mikrog